PlainRecalls
FDA Drug Moderate Class II Terminated

Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7 mL bottle, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 49884-161-11.

Reported: April 5, 2023 Initiated: March 2, 2023 #D-0475-2023

Product Description

Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7 mL bottle, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 49884-161-11.

Reason for Recall

Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.

Details

Units Affected
372,938 bottles
Distribution
Nationwide in the USA and Puerto Rico
Location
Malvern, PA

Frequently Asked Questions

What product was recalled?
Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200 International Units/spray, 3.7 mL bottle, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 49884-161-11.. Recalled by Endo Pharmaceuticals, Inc.. Units affected: 372,938 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 5, 2023. Severity: Moderate. Recall number: D-0475-2023.